Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Cardiol Therapeutics Inc T.CRDL.W.A


Primary Symbol: T.CRDL Alternate Symbol(s):  CRDL

Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.


TSX:CRDL - Post by User

Post by Youhillmanon May 06, 2021 12:53am
282 Views
Post# 33138589

Bought Deal with Raymond James

Bought Deal with Raymond James

A bit surprised by the bought deal today with Raymond James although CRDL did file a soft prospectus almost 2 weeks ago so maybe I shouldn't have been. 

CRDL still has lots of cash to run the business so we can rule that out in terms of why they did the bought deal.

I believe this is a prelude to a listing on the NASDAQ, history tells me the NASDAQ listing should now occur within the next 4-8 weeks.

If this is in fact the case, I believe you will see CRDL go from $3.60 to somewhere between $8-10 within days of the NASDAQ listing.

The next milestone will be FDA approval in August to October whereby CRDL becomes a Billion Dollar Company.

<< Previous
Bullboard Posts
Next >>